ASMI's Board of Directors

 

ASMI's Board of Directors 2017-18

Chairperson

Lindsay Forrest
Consultant

 

 

Lindsay Forrest pic

 

 

Vice Chair

Doug Cunningham
Managing Director
Johnson & Johnson Pacific Pty Limited

Doug Cunningham

Secretary

James Jones
Commercial Country Manager
Takeda Pharmaceuticals Australia

James Jones

 

Board Members 2017-18

 

 Robert Barnes
 Head of Consumer OTC Division
 Aspen Pharmacare Australia

 

 

 Robert Barnes

Glenn Cochran
Regional Director ANZ - Health
RB

Glenn ASMI new

Andrew Jenkin
General Manager, Australia & New Zealand
Pfizer PFE Australia Pty Ltd

Andrew Jenkin

Stephen Moodey
ANZ Finance Director
GlaxoSmithKline (Australia)

Stephen Moodey

 

Alan Oppenheim
Managing Director
Ego Pharmaceuticals

 

 

Alan Oppenheim

Mark Sargent
General Manager, Australia & New Zealand
Bayer Healthcare Consumer Care

Mark Sargent

Seona Wallace  
Managing Director
HealthOne

Seona

ASMI Board of Directors Elections

As a company limited by guarantee, ASMI is governed by a constitution and a Board of Directors with the following attributes:
  • Up to 6 Official Delegates elected by ASMI ordinary members
  • Up to 4 skills based directors appointed by the board and may include up to 2 honorary life members and associate members